[Renin as a target of direct pharmacological block in arterial hypertension]
- PMID: 19799192
[Renin as a target of direct pharmacological block in arterial hypertension]
Abstract
Renin is a basic component of renin-angiotensin-aldosteron system which contributes much to the activity of this system. Renin and its precursor prorenin can interact with prorenin receptors thus inducing hypertrophy and fibrogenesis in target tissues. Many variants of arterial hypertension are associated with plasmic renin activation suggesting high efficacy of direct renin inhibitors. Large controlled clinical trials demonstrated that one of such inhibitors, aliskiren, reduces high blood pressure and damage to target organs.
Similar articles
-
Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.Minerva Endocrinol. 2009 Dec;34(4):333-8. Minerva Endocrinol. 2009. PMID: 20046162 Review.
-
[Renin inhibitors--new direction in the treatment of arterial hypertension].Ter Arkh. 2010;82(9):53-9. Ter Arkh. 2010. PMID: 21086622 Review. Russian.
-
[Renin inhibition in hypertension].Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:15-22. Turk Kardiyol Dern Ars. 2009. PMID: 20019472 Turkish.
-
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.J Renin Angiotensin Aldosterone Syst. 2008 Sep;9(3):163-75. doi: 10.1177/1470320308096411. J Renin Angiotensin Aldosterone Syst. 2008. PMID: 18957387 Clinical Trial.
-
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.Adv Ther. 2009 Jul;26(7):700-10. doi: 10.1007/s12325-009-0050-5. Epub 2009 Jul 27. Adv Ther. 2009. PMID: 19649581 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical